v3.26.1
Note 11 - Segment Information - Reconciliation of Expense Categories (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
REVENUES $ 60,531   $ 65,163   $ 24,643 $ 196,875
Cost of goods sold 732,496   509,688   1,394,641 811,694
Research and development 3,675,716   2,857,179   7,736,253 5,762,807
General and administrative 1,430,332   1,263,137   3,809,495 2,529,797
Total Costs and Expenses 7,485,486   5,756,865   15,759,954 11,308,991
Loss from Operations (7,424,955)   (5,691,702)   (15,735,311) (11,112,116)
Interest income 377,533   369,804   644,146 481,892
Foreign currency exchange (loss) gain (683,434)   1,285,261   (281,024) 1,159,493
Other expense (15,310)   (7,199)   (15,310) (9,799)
Total Other Income (Expense) 43,194   (2,103,620)   (9,403,461) (2,029,237)
Net loss (7,381,761) $ (17,757,011) (7,795,322) $ (5,346,031) (25,138,772) (13,141,353)
Operating Segments [Member]            
REVENUES 60,531   65,163   24,643 196,875
Cost of goods sold 732,496   509,688   1,394,641 811,694
Sales expenses 704,356   691,215   1,420,116 1,314,796
Marketing expenses 942,586   435,646   1,399,449 889,897
Regulatory affairs and quality assurance expenses 844,088   809,950   1,839,628 1,670,954
General and administrative 1,430,332   1,263,136   3,809,495 2,529,796
Total Costs and Expenses 7,485,486   5,756,865   15,759,954 11,308,991
Loss from Operations (7,424,955)   (5,691,702)   (15,735,311) (11,112,116)
Interest income 377,533   369,804   644,146 481,892
Foreign currency exchange (loss) gain (683,434)   1,285,261   (281,024) 1,159,493
Other expense 349,095   (3,758,685)   (9,766,583) (3,670,622)
Total Other Income (Expense) 43,194   (2,103,620)   (9,403,461) (2,029,237)
Net loss (7,381,761)   (7,795,322)   (25,138,772) (13,141,353)
Operating Segments [Member] | Equipment Revenue [Member]            
REVENUES 8,782   13,247   17,317 20,811
Operating Segments [Member] | Consumable Revenue [Member]            
REVENUES 29,615   30,965   (35,182) 134,986
Operating Segments [Member] | Service [Member]            
REVENUES 22,134   20,951   42,508 41,078
Operating Segments [Member] | Clinical Research [Member]            
Research and development 1,097,375   570,057   2,205,874 1,137,288
Operating Segments [Member] | Product and Service, Other [Member]            
Research and development $ 1,734,253   $ 1,477,173   $ 3,690,751 $ 2,954,566